Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 12 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001To the editor: RE: Henriques T, Olerud C, Petren-Mallmin M, et al. Cauda equina syndrome as a postoperative complication in five patients operated for lumbar disc herniation. Spine 2001;26, 293-7.Fraser, Robert D.
2001Mechanical and pathologic consequences of induced concentric anular tears in an ovine modelFazzalari, N.; Costi, J.; Hearn, T.; Fraser, R.; Vernon-Roberts, B.; Hutchinson, J.; Manthey, B.; Parkinson, I.; Sinclair, C.
2001Comparison of fusion in approved interbody fusion devices - Lumbar I/F cageFraser, Robert D.
2001Regulation of calcitonin receptor by glucocorticoid in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kB ligand and macrophage colony-stimulating factorWada, S.; Yasuda, S.; Nagai, T.; Maeda, T.; Kitahama, S.; Suda, S.; Findlay, D.; Iitaka, M.; Katayama, S.
2001A long-term review of a modified Evans procedure - A 5- to 15-year follow-up of 111 anklesNimon, G.; Dobson, P.; Angel, K.; Lewis, P.; Stevenson, T.
2001The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysisHaynes, D.; Crotti, T.; Potter, A.; Loric, M.; Atkins, G.; Howie, D.; Findlay, D.
2001The ratio of messenger RNA levels of receptor activator of nuclear factor kB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritisFazzalari, N.; Kuliwaba, J.; Atkins, G.; Forwood, M.; Findlay, D.
2001Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic jointHaynes, D.; Crotti, T.; Loric, M.; Bain, G.; Atkins, G.; Findlay, D.
2001Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAILClayer, M.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Atkins, G.; Findlay, D.
2001Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosisAtkins, G.; Evdokiou, A.; Bouralexis, S.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.